GliaPharm SA

Private

GenevaHealthcare & Life Scienceshttps://gliapharm.com/

Last Round

Grant

Dec 14, 2023

Total Funding Raised

$6.46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

GliaPharm SA is a biotechnology company that develops small molecule therapies targeting glial cells to treat neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoverysmall-molecule therapeuticsglial metabolismneurological disordersneurodegenerative diseasesbrain energy homeostasisbiotech startupAI-driven drug discoveryin silico drug discoverypreclinical researchpsychiatric disordersdrug pipelinebiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GliaPharm SA Comparables

Compare GliaPharm SA with similar companies based on industry and business-model similarity.

GliaPharm SA comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AstronauTx	86%
Cerecin	72%
ScandiBio Therapeutics	70%

View all Comparables

GliaPharm SA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Dec 14, 2023
Debt	Jul 4, 2022
Seed	May 25, 2020
Debt	Aug 6, 2018

View all Funding Rounds

GliaPharm SA Investors

Notable investors and investment history

GliaPharm SA investors
Investor	Rounds
Foundation for Technological Innovation	Debt
Alzheimer's Drug Discovery Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 6, 2026
Monthly visitors grew 131% MoM, reaching 1.3K.
May 25, 2020
$2.06M round raised.

View all signals

GliaPharm SA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GliaPharm SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GliaPharm SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva

Employee Range6

Year Founded2016

Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.